Most Read News

Scheme becomes effective from 01 April 2022

Biocon announced that the Health Products Regulatory Authority (HPRA), Ireland, conducted a GMP inspection of one of Biocon Biologics new monoclonal antibody drug substance manufacturing facilities in Biocon Park, Bengaluru, India, between 28 March and 01 April 2022. The inspection report contains no critical observations and only one of the deficiencies is categorized as major which is being addressed expeditiously in consultation with the regulatory […]

with effect from 31 July 2022

Sales rise 55.89% to Rs 74.89 crore

For consideration of Rs 64 cr

Used in treatment of cancer of plasma cells and lymph nodes

The Indian rupee is expected to stay cautious on Wednesday, 04 May 2022 awaiting cues from the Federal Reserve later in the global day. Besides, the dollar index hovering near a 20-year peak on expectations of aggressive rate hike by the US central bank with inflation running at its fastest pace in 40 years is expected to weigh down the domestic unit. On Monday, rupee […]

By 08 September 2022

SGX Nifty: Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could rise 94 points at the opening bell. Meanwhile, subscription for the initial public offering (IPO) of insurance behemoth Life Insurance Corporation (LIC) of India has opened today and it will remain open for bidding till 9th May 2022. The IPO price band is Rs 902 to Rs […]

On and from 30 June 2022